Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nalmefene”

Showing 16 of 0 results

Not applicableUnknownNCT02752503
What this trial is testing

Nalmefene in Alcohol Dependence and Borderline Personality Disorder

Who this might be right for
Alcohol Use DisorderBorderline Personality Disorder
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Post-approval studies (Phase 4)WithdrawnNCT05808881
What this trial is testing

Clinical Outcomes From Nalmefene

Who this might be right for
Opioid Overdose
Purdue Pharma LP
Testing effectiveness (Phase 2)Study completedNCT03034408
What this trial is testing

Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects

Who this might be right for
Alcohol Use Disorder
Prof. Daniele Zullino 37
Early research (Phase 1)Study completedNCT01934166
What this trial is testing

Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
H. Lundbeck A/S 32
Early research (Phase 1)Study completedNCT03279562
What this trial is testing

Patient Driven Recovery With Nalmefene and Coaching

Who this might be right for
Opioid-use DisorderHarmful; Use, Alcohol
Yale University 10
Early research (Phase 1)Study completedNCT02679469
What this trial is testing

A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects

Who this might be right for
Alcohol Dependence
Otsuka Pharmaceutical Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT03278886
What this trial is testing

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene

Who this might be right for
HIV InfectionAlcohol UsePain
Boston Medical Center 11
Early research (Phase 1)Looking for participantsNCT07325279
What this trial is testing

Nalmefene Implant in Healthy Subjects

Who this might be right for
Opioid Abuse and Addiction
ReacX Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00132119
What this trial is testing

Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

Who this might be right for
Pathological Gambling
Somaxon Pharmaceuticals 233
Testing effectiveness (Phase 2)Study completedNCT00202696
What this trial is testing

Nalmefene Smoking Cessation Study

Who this might be right for
Smoking Cessation
Somaxon Pharmaceuticals 76
Early research (Phase 1)Study completedNCT04828005
What this trial is testing

Pharmacodynamic Evaluation of Intranasal Nalmefene

Who this might be right for
Pharmacodynamic
Opiant Pharmaceuticals Inc 84
Large-scale testing (Phase 3)WithdrawnNCT02824354
What this trial is testing

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

Who this might be right for
CirrhosisAlcohol DependenceNalmefene
Centre Hospitalier Universitaire, Amiens
Very early researchEnded earlyNCT02372318
What this trial is testing

Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity

Who this might be right for
Alcoholism
Central Institute of Mental Health, Mannheim 23
Large-scale testing (Phase 3)Study completedNCT00811941
What this trial is testing

Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 665
Not applicableStudy completedNCT04107051
What this trial is testing

Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

Who this might be right for
Alcohol Dependence
Otsuka Pharmaceutical Co., Ltd. 533
Early research (Phase 1)Study completedNCT02639273
What this trial is testing

Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation

Who this might be right for
AUD
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 13

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation